Neumeyer J L, Reischig D, Arana G W, Campbell A, Baldessarini R J, Kula N S, Watling K J
J Med Chem. 1983 Apr;26(4):516-21. doi: 10.1021/jm00358a011.
The enantiomers [(S)-(+) and (R)-(-)] of N-n-propylnorapomorphine (NPA) were synthesized. (R)-NPA was obtained by the acid-catalyzed rearrangement of N-n-propylnormorphine. (R)-NPA also was converted to (RS)-N-n-propylnorapomorphine dimethyl ether by dehydrogenation of the 10,11-O,O'-dimethyl ether of (R)-NPA with 10% palladium on carbon in acetonitrile, followed by reduction with sodium cyanoborohydride under acidic conditions. Alternatively (RS)-NPA 10,11-O,O'-dimethyl ether was obtained via total synthesis. (+)-Dibenzoyl-D-tartaric acid was used to resolve (RS)-NPA dimethyl ether. Ether cleavage gave (S)-NPA isolated as the hydrochloride salt in greater than 99.9% enantiomeric purity, as determined by circular dichroism (CD) spectra. The pharmacological activities of (S)- and (R)-NPA were evaluated with subnanomolar concentrations of 3H-labeled apomorphine (APO), ADTN, and spiroperidol (SPR) for competition for binding to a membrane-rich subsynaptosomal fraction of calf caudate nucleus. IC50 (nM) values for (R)-NPA vs. (S)-NPA were as follows: [3H]APO, 2.5 vs. 66; [3H]ADTN, 2.0 vs. 60; [3H]SPR, 174 vs. 1400. The efficacy of (R)- and (S)-NPA in stimulating dopamine-sensitive adenylate cyclase from both homogenates of rat corpus striatum and pieces of intact carp retina was also evaluated. Three behavioral effects in the rat (stereotyped behavior, sedation, and catalepsy) were also examined. Only (R)-NPA induced stereotypy; (S)-NPA failed to antagonize this action of the R isomer. The effects of (R)- and (S)-NPA on adenylate cyclase agreed with the behavioral effects and radioreceptor binding assays in that the R isomer was the strongly preferred enantiomer at dopamine receptors. The S enantiomer of NPA was, however, the weakly preferred configuration for rat liver catechol O-methyltransferase. A dopamine-receptor model accommodates the configuration of NPA and related aporphines.
合成了N -正丙基去甲阿扑吗啡(NPA)的对映体[(S)-(+)和(R)-(-)]。(R)-NPA通过N -正丙基去甲吗啡的酸催化重排获得。(R)-NPA还通过在乙腈中用10%钯 - 炭将(R)-NPA的10,11 - O,O'-二甲基醚脱氢,然后在酸性条件下用氰基硼氢化钠还原,转化为(RS)-N -正丙基去甲阿扑吗啡二甲醚。或者,(RS)-NPA 10,11 - O,O'-二甲基醚通过全合成获得。(+)-二苯甲酰 - D -酒石酸用于拆分(RS)-NPA二甲醚。醚键裂解得到(S)-NPA,以盐酸盐形式分离,对映体纯度大于99.9%,通过圆二色性(CD)光谱测定。用亚纳摩尔浓度的3H标记的阿扑吗啡(APO)、ADTN和螺哌啶醇(SPR)竞争结合小牛尾状核富含膜的亚突触体部分,评估了(S)-和(R)-NPA的药理活性。(R)-NPA与(S)-NPA的IC50(nM)值如下:[3H]APO,2.5对66;[3H]ADTN,2.0对60;[3H]SPR,174对1400。还评估了(R)-和(S)-NPA对大鼠纹状体匀浆和完整鲤鱼视网膜片的多巴胺敏感腺苷酸环化酶的刺激作用。还研究了大鼠的三种行为效应(刻板行为、镇静和僵住)。只有(R)-NPA诱导刻板行为;(S)-NPA未能拮抗R异构体的这种作用。(R)-和(S)-NPA对腺苷酸环化酶的作用与行为效应和放射受体结合测定结果一致,即R异构体是多巴胺受体上强烈优先选择的对映体。然而,NPA的S对映体是大鼠肝脏儿茶酚 - O -甲基转移酶较弱优先选择的构型。一个多巴胺受体模型符合NPA和相关阿朴啡的构型。